SD |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
4.6 |
null |
0.2 |
0.49 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
2 |
days |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
98871 |
2160 |
SD |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
4.4 |
null |
0.4 |
0.98 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
5 |
days |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
98873 |
2160 |
SD |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
5.2 |
null |
0.2 |
0.49 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
720 |
min |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
98868 |
2160 |
SD |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
5.3 |
null |
0.2 |
0.49 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
5 |
days |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
98872 |
2160 |
SD |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
4.4 |
null |
0.4 |
0.98 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
360 |
min |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
98867 |
2160 |
SD |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
5.1 |
null |
0.5 |
1.22 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
360 |
min |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
98866 |
2160 |
SD |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
5.9 |
null |
0.3 |
0.73 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
2 |
days |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
98870 |
2160 |
SD |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
4.5 |
null |
0.5 |
1.22 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
720 |
min |
heart left ventricle end-diastolic diameter to posterior wall thickness ratio |
98869 |
2160 |